Minimally modified oligonucleotides - Combination of end-capping

Biological Chemistry Hoppe-Seyler

Volumn 377, Issue 1, 1996, Pages 67-70

  Pyrimidine Protection, ^a   Peyman, Anusch ^a   Uhlmann, Eugen ^a  

^a SANOFI   (France)

Author keywords

Nuclease resistance; Oligonucleotides; Partial modification; Protection pattern

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; NUCLEASE; OLIGONUCLEOTIDE; PHOSPHOROTHIOIC ACID;

ANIMAL CELL; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; METHODOLOGY; NONHUMAN; NUCLEOTIDE METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MOLECULAR SEQUENCE DATA; NUCLEIC ACID DENATURATION; OLIGONUCLEOTIDES, ANTISENSE; PYRIMIDINES;

EID: 0030020391     PISSN: 01773593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Agrawal, S., Mayrand, S.H., Zamecnik, P.C., and Pederson, T. (1990). Site-specific excision from RNA by RNase H and mixed-phosphate-backbone oligodeoxynucleotides. Proc. Natl. Acad. Sei. USA 87,1401 -1405.
2. bcr"abl tyrosine kinase autophosphorylation by oiigodeoxynucleotides of defined sequence and backbone structure. Nucleic Acids Res. 22, 2150-2154.
3. Crooke, ST., and Lebleu, B., eds. (1993). Antisense Research and Applications. (Boca Raton, USA: CRC Press).
4. Gao, W.-Y, Han, F.-S., Storm, C., Egan, W., and Cheng, Y.-C. (1991). Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNaseH: Implications for antisense technology. Molecular Pharmacology 41,223-229.
5. Ghosh, M., Ghosh, K. and Cohen, J.S. (1993). Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application. Anti-Cancer Drug Design 8,15-32.
6. Giles, R.V., Spilier, D.G., and Tidd, D.M. (1993). Chimeric oligodeoxynucleotide analogues: enhanced cell uptake of structures which direct ribonuclease H with high specificity. Anti-Cancer Drug Design 3,33-51.
7. Giles, R.V., Ruddell, C.J., Spiller, D.G., Green, J.A., and Tidd, D.M. (1995). Single base discrimination for ribonuclease H-dependent antisense effects within intact leukaemia cells. Nucleic Acid Res. 23,954-961.
8. Guvakova, M.A., Yakubov, LA., Vlodavsky, I., Tonkinson, J.L, and Stein, C.A. (1995). Phosphorothioate oligonucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity sites on extracellular matrix. J. Biol. Chem. 270,2620-2627.
9. Hoke, G.D., Draper, K., Freier, S., Gonzalez, C., Driver, V.B., Zounes, M.C., and Ecker, D.J. (1991). Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucleic Acid Res. 19,5743-5748.
10. Maury, G., Abdelaziz, E., Mon/an, F., Muller, B., Imbach, J., and Goody, R.S. (1992). Template, phosphorothioate oligonucleotides duplexes as inhibitors of HIV-1 reverse transcriptase. Biochem. Biophys. Res. Commun. 186,1249-1256.
11. Peyman, A., Helsberg, M., Kretzschmar, G., Mag, M., Grabley, S., and Uhlmann, E. (1995). Inhibition of viral growth by antisense oligonucleotides directed against the IE110 and the UL30 mRNA of Herpes Simplex Virus Type-1. Biol. Chem. HoppeSeyler 376,195-198.
12. Stein, C.A., Subasinghe, C., Shinozuka, K., and Cohen, J.S. (1988). Physicochemical properties of phosphorothioate oligodeoxynucleotides. Nucl. Acids Res. 16,3209-3221.
13. Stein, C.A., and Cheng, Y.-C. (1993). Antisense oligonucleotides as therapeutic agents - Is the bullet really magical? Science 267,1004-1912.
14. Stein, C.A., Tonkinson, J., Zhang, L.M., Yakubov, L, Gervasoni, J., Taub, R., and Rotenberg, S.A. (1993). Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry 32,4855-4861.
15. Teasdale, R.M., Maison, S.J., Fisher, E., and Krieg, A.M. (1994). Inhibition of T4 polynucleotide kinase activity by phosphorothioate and chimeric oligodeoxynucleotides. Antisense Research and Development 4,295-297.
16. Uhlmann, E., and Peyman, A. (1990). Antisense oligonucleotides -A new therapeutic principle. Chem. Rev. 90,543-584.